Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122693903 | 12269390 | 3 | F | 20160202 | 20160727 | 20160414 | 20160801 | EXP | JP-JNJFOC-20160411485 | JANSSEN | 69.00 | YR | E | M | Y | 0.00000 | 20160801 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122693903 | 12269390 | 1 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | U | 0 | 3 | MG/KG | LYOPHILIZED POWDER | ||||||
122693903 | 12269390 | 2 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | U | 0 | 3 | MG/KG | LYOPHILIZED POWDER | ||||||
122693903 | 12269390 | 3 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | U | 0 | 3 | MG/KG | LYOPHILIZED POWDER | ||||||
122693903 | 12269390 | 4 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | U | 0 | 3 | MG/KG | LYOPHILIZED POWDER | ||||||
122693903 | 12269390 | 5 | PS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | 35TH DOSE | U | U | 103772 | 4 | MG/KG | LYOPHILIZED POWDER | |||||
122693903 | 12269390 | 6 | SS | RHEUMATREX | METHOTREXATE SODIUM | 1 | Oral | U | 0 | 6 | MG | UNSPECIFIED | /wk | ||||||
122693903 | 12269390 | 7 | C | ISONIAZID. | ISONIAZID | 1 | Oral | 0 | 300 | MG | UNSPECIFIED | QD | |||||||
122693903 | 12269390 | 8 | C | BAKTAR | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
122693903 | 12269390 | 9 | C | PARIET | RABEPRAZOLE SODIUM | 1 | Oral | 0 | 10 | MG | UNSPECIFIED | QD | |||||||
122693903 | 12269390 | 10 | C | FOLIAMIN | FOLIC ACID | 1 | Oral | 0 | 5 | MG/KG | UNSPECIFIED | /wk | |||||||
122693903 | 12269390 | 11 | C | MAGMITT | MAGNESIUM OXIDE | 1 | Oral | 0 | 330 | MG | UNSPECIFIED | TID | |||||||
122693903 | 12269390 | 12 | C | BUP-4 | PROPIVERINE | 1 | Oral | 0 | 20 | MG | UNSPECIFIED | BID | |||||||
122693903 | 12269390 | 13 | C | CELECOX | CELECOXIB | 1 | Oral | 0 | 200 | MG | UNSPECIFIED | BID | |||||||
122693903 | 12269390 | 14 | C | REMINYL | GALANTAMINE | 1 | Oral | 0 | 8 | MG | UNSPECIFIED | BID | |||||||
122693903 | 12269390 | 15 | C | NICERGOLINE | NICERGOLINE | 1 | Oral | 0 | 5 | MG | UNSPECIFIED | BID | |||||||
122693903 | 12269390 | 16 | C | POSTERISAN | LIDOCAINE | 1 | Topical | 0 | UNSPECIFIED | ||||||||||
122693903 | 12269390 | 17 | C | LOXONIN | LOXOPROFEN SODIUM | 1 | Topical | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
122693903 | 12269390 | 1 | Rheumatoid arthritis |
122693903 | 12269390 | 2 | Rheumatoid arthritis |
122693903 | 12269390 | 3 | Rheumatoid arthritis |
122693903 | 12269390 | 4 | Rheumatoid arthritis |
122693903 | 12269390 | 5 | Rheumatoid arthritis |
122693903 | 12269390 | 6 | Rheumatoid arthritis |
122693903 | 12269390 | 7 | Antibiotic prophylaxis |
122693903 | 12269390 | 9 | Peptic ulcer |
122693903 | 12269390 | 10 | Prophylaxis |
122693903 | 12269390 | 11 | Constipation |
122693903 | 12269390 | 12 | Benign prostatic hyperplasia |
122693903 | 12269390 | 13 | Rheumatoid arthritis |
122693903 | 12269390 | 16 | Haemorrhoids |
122693903 | 12269390 | 17 | Rheumatoid arthritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
122693903 | 12269390 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
122693903 | 12269390 | Pneumocystis jirovecii pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
122693903 | 12269390 | 1 | 20101105 | 0 | ||
122693903 | 12269390 | 2 | 20110527 | 0 | ||
122693903 | 12269390 | 3 | 20130802 | 0 | ||
122693903 | 12269390 | 4 | 20131220 | 0 | ||
122693903 | 12269390 | 5 | 20151211 | 0 | ||
122693903 | 12269390 | 6 | 2009 | 20160205 | 0 | |
122693903 | 12269390 | 7 | 20101015 | 20110623 | 0 | |
122693903 | 12269390 | 8 | 20150615 | 0 |